Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02677740 · ClinicalTrials.gov registry record · NA
Mechanisms of Non-Invasive Neuromodulation Interventions: Influence on Human Neurochemistry and Functional Connectivity
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02677740: Completed NA study, sponsored by University of Minnesota.
NCT02677740 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02677740, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The aim of this project is to increase our understanding of how two different protocols of repetitive transcranial magnetic stimulation (rTMS), inhibitory (1 Hz) and excitatory (5 Hz), applied over the primary motor cortex of the presumed dominant hemisphere, affect functional connectivity and neurochemistry in the brain.
Primary Outcome
GABA concentration is quantified with MRS at 7 Tesla. Percent change of GABA concentration is calculated from baseline (i.e., pre-rTMS).
Interventions
- DEVICE Inhibitory rTMS (1 Hz)
- DEVICE Excitatory rTMS (5 Hz)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-08-29 |
| Est. Completion | 2017-03-19 |
| Phase | NA |
What the finished NCT02677740 record still lists
NCT02677740 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Inhibitory rTMS (1 Hz) is the first listed.
NCT02677740 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02677740 about?
NCT02677740 is a clinical study titled "Mechanisms of Non-Invasive Neuromodulation Interventions: Influence on Human Neurochemistry and Functional Connectivity". The aim of this project is to increase our understanding of how two different protocols of repetitive transcranial magnetic stimulation (rTMS), inhibitory (1 Hz) and excitatory (5 Hz), applied over the primary motor cortex of the presumed dominant hemisphere, affect functional connectivity and neuro...
What is the current status of trial NCT02677740?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2016-08-29. Estimated completion is 2017-03-19.
What interventions are being tested in trial NCT02677740?
The interventions under investigation include: Inhibitory rTMS (1 Hz) (DEVICE), Excitatory rTMS (5 Hz) (DEVICE).
Who is sponsoring clinical trial NCT02677740?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02677740's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI